Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;35(10):5352-5364.
doi: 10.1002/ptr.7144. Epub 2021 Jun 8.

Quercetin and metabolic syndrome: A review

Azar Hosseini  1 , Bibi Marjan Razavi  2   3 , Maciej Banach  4 , Hossein Hosseinzadeh  3   5
Affiliations
Review

Quercetin and metabolic syndrome: A review

Azar Hosseini et al. Phytother Res. 2021 Oct.

Abstract

Metabolic syndrome (MetS) is a complex of diseases that lead to mortality due to the development of cardiovascular problems. Quercetin, as an important flavonoid, has various properties such as decreasing blood pressure, anti-hyperlipidemia, anti-hyperglycemia, anti-oxidant, antiviral, anticancer, anti-inflammatory, anti-microbial, neuroprotective, and cardio-protective effects. In this review article, we collected original articles from different sources such as Google Scholar, Medline, Scopus, and Pubmed, which is related to the effect of quercetin on the improvement of the signs of MetS, including elevated glucose level, hyperlipidemia, obesity, and blood pressure. According to these data, quercetin may also have a role in the management of metabolic disorders via different mechanisms such as increasing adiponectin, decreasing leptin, anti-oxidant activity, reduction of insulin resistance, the elevation of insulin level, and blocking of calcium channel. We have attempted to make some recommendations on the quercetin application in patients. However, it needs to do further clinical trials and more investigations to show the real clinical value of quercetin on metabolic syndrome.

Keywords: diabetes; dyslipidemia; hypertension; metabolic syndrome; obesity; quercetin.

PubMed Disclaimer

References

REFERENCES

    1. Abdelmoaty, M. A., Ibrahim, M., Ahmed, N., & Abdelaziz, M. (2010). Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats. Indian Journal of Clinical Biochemistry, 25(2), 188-192.
    1. Abuzaid, A. A., Osman, M. A., & Elkhawad, A. O. (2017). Quercetin ameliorates chronic type 2 diabetes induced by long-term high-fat, high-sucrose diet via modifying expression of genes involved in energy homeostasis and inflammation. Journal of Pharmaceutical Sciences & Emerging Drugs, 4, 2. https://doi.org/10.4172/2380-9477.1000117
    1. Aguirre, L., Arias, N., Macarulla, M. T., Gracia, A., & Portillo, M. P. (2011). Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J, 4(1), 189-198. https://doi.org/10.2174/1876396001104010189.
    1. Ahn, J., Lee, H., Kim, S., Park, J., & Ha, T. (2008). The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochemical and Biophysical Research Communications, 373(4), 545-549. https://doi.org/10.1016/j.bbrc.2008.06.077.
    1. Akaberi, M., & Hosseinzadeh, H. (2016). Grapes (Vitis vinifera) as a potential candidate for the therapy of the metabolic syndrome. Phytotherapy Research, 30(4), 540-556. https://doi.org/10.1002/ptr.5570.

LinkOut - more resources